4Kannel WB, Wolf PA Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol ,1998,82:2N-9N.
7Jouven X, Desnos M, Guerot C, et al. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study Ⅰ. Eur Heart J, 1999,20:896-899.
8Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002,347:1825-1833.
9Hagens VE, Ranchor AV, Van Sonderen E,et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol,2004,43:241-247.
10Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation,2001,104:2118-2150.
二级参考文献12
1Saoudi N,Schoels W,EL-Sherif N,eds.Atrial flutter and fibrillation:from basic to clinical applications[]..1998
2Wolf PA,Abbott RD,Kannel WB.Atrial fibrillation as an independent risk factor for stroke: the Framingham study[].Stroke.1991
3Caro JJ,Flegel KM,Orejuela ME,et al.Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice[].Canadian Medical Association Journal.1999
4Flegel KM,Shipley MJ,Rise G.Risk of stroke in non-rheumatic atrial fibrillation[].The Lancet.1987
5Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation[].Stroke.2000
6Hart RG,Sherman DG,Easton JD,et al.Prevention of stroke in patients with nonvalvular atrial fibrillation[].Neurology.1998
7Peterson P,Boysen G,Godtfredsen J,et al.Placebo controlled,randomized trial of warfarin and aspirin for prevention of thromboembolic complications on chronic atrial fibrillation: the Compenhagen AFASAK study[].The Lancet.1989
8Feinberg WM,Blackshear JL,Laupacis A,et al.Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications[].Archives of Internal Medicine.1995
9Ezekowitz MD,Bridgers SL,James KE,et al.Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation:Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators[].The New England Journal of Medicine.1992
10Connolly SJ,Laupacis A,Gent M,et al.Canadian atrial fibrillation anticoagulation (CAFA) study[].Journal of the American College of Cardiology.1991